Fig. 2From: [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary resultsCumulative survival from study entry to Follow up (event is the primary endpoint, start of systemic therapy)Back to article page